83 POSTER A phase I study examining weekly weight based or fixed dosing and pharmacokinetics (PK) of a novel spectrum kinase inhibitor, XL999, in patients (pts) with advanced solid malignancies (ASM)

✍ Scribed by M. Mita; J. Cooper; A. Ricart; A. Mita; C. Takimoto; S. Britt; A. Tolcher; A. Dowlati; K. Papadopoulos

• Book ID: 118623712
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 60 KB
• Volume: 4
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(06)70089-1